Coagulation factor concentrates fail to restore alterations in fibrin formation caused by rivaroxaban or dabigatran in studies with flowing blood from treated healthy volunteers - Arellano-Rodrigo, E; Lopez-Vilchez, I; Galan, A M (Transfus Med Rev, 2015)
, et al.